Potassium 4‐Methoxysalicylate ( 4MSK ) Exerts a Skin Lightening Effect by Acting on Melanocytes and Keratinocytes
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.70112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Yutaka Shirasugi und 7 weiteren Autor:innen. Beteiligte Einrichtung: MIRAI Technology Institute, Shiseido Co. Ltd., Yokohama, Japan. Hauptthemen laut MEDLINE: Hyperpigmentation, Keratinocytes, Melanocytes, Skin Lightening Preparations. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hyperpigmentation is a common acquired disorder that can be a cosmetic concern for many individuals. To reduce and prevent hyperpigmentation, numerous skin lightening agents have been developed. Potassium 4‐methoxysalicylate (4MSK) is a skin lightening agent that was approved as an active skin lightening ingredient of quasi‐drugs by the Ministry of Health, Labour and Welfare of Japan in 2003. For over 20 years, 4MSK has been widely used in quasi‐drug and cosmetic products. However, the mechanism of action and efficacy of 4MSK on skin pigmentation and skin lightness have not been publicly reported.
Aims
This study aimed to assess the mechanism of action and the efficacy of 4MSK on facial pigmentation.
Methods
The mechanism of action of 4MSK on epidermal cells was investigated using human melanocytes, human keratinocytes, and human 3D epidermal equivalents. The efficacy of 4MSK on facial pigmentation was evaluated by a human clinical study, which is a double‐blind, split‐face, placebo‐controlled, paired‐design study.
Results
4MSK significantly suppressed melanin content in cultured human melanocytes and a 3D epidermal equivalent. It also promoted gene expression of differentiation markers of human keratinocytes. In the clinical study, a 4MSK formulation significantly increased skin lightness values in both pigmented and non‐pigmented areas of cheek skin. In addition, it reduced the desquamation area ratio of the cheek.
Conclusions
4MSK reduces skin pigmentation and contributes to brighter skin by acting on both melanocytes and keratinocytes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MIRAI Technology Institute, Shiseido Co. Ltd., Yokohama, Japan.
- Department of Dermatology, Ikebukuro West Gate Hospital, Tokyo, Japan.
ORCID-Profile: Yutaka Shirasugi, Takako Shibata, Masao Hara, Aska Sonoki, Yoko Funasaka
Zitieren
APA
Shirasugi, Y., Shibata, T., Koike, S., Hara, M., Hasegawa, K., Iino, M., Sonoki, A., & Funasaka, Y. (2025). Potassium 4‐Methoxysalicylate ( 4MSK ) Exerts a Skin Lightening Effect by Acting on Melanocytes and Keratinocytes. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70112
Vancouver
Shirasugi Y, Shibata T, Koike S, Hara M, Hasegawa K, Iino M, et al. Potassium 4‐Methoxysalicylate ( 4MSK ) Exerts a Skin Lightening Effect by Acting on Melanocytes and Keratinocytes. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70112
BibTeX
@article{Shirasugi2025,
author = {Shirasugi, Yutaka and Shibata, Takako and Koike, Saaya and Hara, Masao and Hasegawa, Kiyotaka and Iino, Masato and Sonoki, Aska and Funasaka, Yoko},
title = {Potassium 4‐Methoxysalicylate ( 4MSK ) Exerts a Skin Lightening Effect by Acting on Melanocytes and Keratinocytes},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.70112}
}
EUVIMED